Loading...
•
Mar 31
Alkermes Q1 2025 Earnings Report
Reports First Quarter 2025 Financial Results
Key Takeaways
Alkermes plc reported first quarter 2025 revenues of $306.5 million and GAAP net income of $22.5 million, with diluted GAAP earnings per share of $0.13. The company reiterated its 2025 financial expectations and highlighted progress in its ALKS 2680 development program.
Total revenues for Q1 2025 were $306.5 million.
GAAP net income for Q1 2025 was $22.5 million, resulting in diluted GAAP EPS of $0.13.
Proprietary net sales increased to $244.5 million in Q1 2025 compared to $233.5 million in Q1 2024.
The company completed enrollment in the Vibrance-1 phase 2 study for ALKS 2680 and expects topline results early in Q3 2025.
Alkermes
Alkermes
Alkermes Revenue by Segment
Revenue by Segment
VIVITROL Revenue
CapyFin.comARISTADA Revenue
CapyFin.comLYBALVI Revenue
CapyFin.comVUMERITY Revenue
CapyFin.comJNJ Royalties Revenue
CapyFin.com Forward Guidance
Alkermes reiterated its full-year 2025 financial expectations as previously set forth on February 12, 2025.
Positive Outlook
- Solid foundation provided by Q1 financial performance to deliver on full-year guidance.
- Strong position in the current macroeconomic environment.
- Focused on executing strategic objectives to drive future value.
- Completed enrollment in the Vibrance-1 phase 2 study for ALKS 2680.
- Strong momentum across the ALKS 2680 development program, preparing for phase 3.
Challenges Ahead
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.